Categories
Retirement planning Swiss

China’s Biotech Rise: What It Means for Roche, Novartis and Swiss Pensions

China spent decades being associated with generic medicines, active pharmaceutical ingredients and low-cost manufacturing. That description is now badly out of date. The more important development for investors is not that China can manufacture drugs cheaply. It is that Chinese companies are increasingly discovering drug candidates, taking them rapidly through early clinical trials and licensing them […]

Categories
English Portfolio Management

Investing in Swiss equities?

Investing in Swiss equities? The answer is yes for investors willing to gain an exposure to Swiss equities and their home currency, the Swiss franc. However, it is strongly influenced by the three largest companies: Nestlé, Novartis and Roche together account for more than half of the market value.

Categories
Français Gestion de portefeuille

Un investissement dans le marché boursier suisse?

La bourse suisse est fortement influencée par les trois plus grandes entreprises : Nestlé, Novartis et Roche représentent ensemble plus de la moitié de la valeur de l’indice.